Cargando…

PERSONALIZING THE OPTIMAL CARDIAC TROPONIN THRESHOLD FOR COVID-19 PROGNOSTICATION BASED ON PRE-EXISTING COMORBIDITIES

Detalles Bibliográficos
Autores principales:	Ruge, Max, de Lavallaz, Jeanne du Fay, Danley, Kelsey T., Gomez, Joanne Michelle D., Gajo, Eileen, Sarau, Alexandra, Simmons, J. Alan, Rao, Anupama, Williams, Kim Allan, Volgman, Annabelle S., Marinescu, Karolina, Suboc, Tisha Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972416/ http://dx.doi.org/10.1016/S0735-1097(22)03053-4

Ejemplares similares

INITIAL TROPONIN LEVEL AS A COVID-19 ILLNESS PROGNOSTICATOR
por: Ruge, Max, et al.
Publicado: (2021)

ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)

HYPERDYNAMIC LEFT VENTRICULAR EJECTION FRACTION IS A POOR PROGNOSTIC SIGN IN COVID-19 INFECTION
por: Ruge, Max, et al.
Publicado: (2021)

PREVALENCE OF PRE-EXISTING ATRIAL FIBRILLATION AND ASSOCIATION WITH IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19
por: Sanders, David, et al.
Publicado: (2022)

CLINICAL CHARACTERISTICS OF NEUROLOGICAL DISEASE AND COVID-19
por: Thakkar, Kajal, et al.
Publicado: (2022)

CHARACTERICS OF HISPANIC, NON HISPANIC WHITE AND NON-HISPANIC BLACK PATIENTS SCREENED AND HOSPITALIZED FOR COVID-19 IN CHICAGO, USA
por: Fugar, Setri, et al.
Publicado: (2021)

CLINICAL PREDICTORS OF COAGULOPATHY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 DISEASE
por: Derbas, Laith, et al.
Publicado: (2021)

BODY MASS INDEX, INFLAMMATION AND SEVERITY IN HOSPITALIZED COVID-19 PATIENTS: RESULTS FROM A CHICAGO AND MADRID RETROSPECTIVE COHORT STUDY
por: Park, Aaron, et al.
Publicado: (2023)

ECHOCARDIOGRAPHIC AND BIOMARKER PREDICTORS FOR IN-HOSPITAL MORTALITY IN COVID-19 DISEASE
por: Gomez, Joanne Michelle D., et al.
Publicado: (2021)

The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients
por: Ruge, Max, et al.
Publicado: (2021)

IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19
por: Ruge, M., et al.
Publicado: (2022)

Prognostic value of H(2)FPEF score in COVID-19
por: Patel, Priya, et al.
Publicado: (2022)

Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19
por: Ruge, Max, et al.
Publicado: (2021)

Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients
por: Rahman, Annas, et al.
Publicado: (2022)

Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease
por: Kerolos, Mina Medhat, et al.
Publicado: (2022)

Cardiovascular findings on chest computed tomography associated with COVID-19 adverse clinical outcomes()
por: Planek, Maria Isabel Camara, et al.
Publicado: (2021)

TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
por: Klinkhammer, Brent, et al.
Publicado: (2021)

TEMPORAL TREND IN MORTALITY FROM COVID-19 ASSOCIATED WITH CARDIOVASCULAR DISEASE
por: Luo, Shengyuan, et al.
Publicado: (2023)

INITIAL, MAXIMUM, AND DELTA TROPONIN AND MORTALITY IN COVID-19
por: Go, Ronaldo, et al.
Publicado: (2021)

INITIAL TROPONIN LEVEL AND ECHOCARDIOGRAPHIC FINDINGS IN SEVERE COVID-19
por: Kumar, Sant, et al.
Publicado: (2021)

CLINICAL IMPACT AND PREDICTORS OF TROPONIN ELEVATION IN PATIENTS WITH COVID-19
por: Case, Brian, et al.
Publicado: (2021)

PREDICTIVE VALUE OF TROPONIN, NTPROBNP AND SODIUM ON ADVERSE CLINICAL OUTCOMES IN COVID-19
por: Roman, Aida, et al.
Publicado: (2021)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

CLINICAL OUTCOMES AND PREDICTORS OF COVID-19 PATIENTS WITH TROPONIN ELEVATION AND CONCOMITANT RENAL DYSFUNCTION
por: Case, Brian, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A MANIFESTATION OF COVID-19 MYOCARDIAL INFLAMMATION ASSOCIATED WITH INCREASED MORTALITY
por: Limaye, Sneha, et al.
Publicado: (2022)

TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
por: Limani, Saurabhkumar M., et al.
Publicado: (2023)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

EFFECTS OF ELEVATED TROPONIN ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE
por: Zhao, Yi, et al.
Publicado: (2022)

PROGNOSTIC VALUE OF ELEVATED HIGH-SENSITIVITY TROPONIN LEVEL IN COVID-19 ASSOCIATED HOSPITALIZATIONS IN THE SOUTH BRONX
por: Yue, Bing, et al.
Publicado: (2021)

COMPARISON OF PROGNOSTIC SIGNIFICANCE OF TROPONIN I ELEVATION TO OTHER BIOMARKERS IN PATIENTS HOSPITALIZED WITH COVID 19 INFECTION
por: Jayanna, Manju Bengaluru, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A PREDICTOR FOR OUTCOMES OF PATIENTS DIAGNOSED WITH COVID 19 INFECTION IN A LARGE PUBLIC HOSPITAL IN THE CHICAGO AREA
por: Quelal, Karol, et al.
Publicado: (2021)

RELATIONSHIP BETWEEN ADMISSION TROPONIN AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH HEART DISEASE AND COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Moreira, Eduardo, et al.
Publicado: (2022)

Editorial commentary: COVID-19 as a cardiovascular disease risk factor
por: Oktay, Ahmet Afşin, et al.
Publicado: (2022)

COVID-19 AND HEART: ASSESSMENT OF TROPONIN AND CARDIOVASCULAR COMORBIDITIES AS PROGNOSTIC MARKERS IN PATIENTS HOSPITALIZED FOR COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Pinesi, Henrique, et al.
Publicado: (2022)

Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound
por: Gomez, Joanne Michelle D., et al.
Publicado: (2022)

SITE-LEVEL VARIABILITY IN THE PROCESSES OF CARE OVER TIME AMONG PATIENTS WITH COVID-19 AND ELEVATED TROPONIN: INSIGHTS FROM THE AMERICAN HEART ASSOCIATION'S CVD COVID-19 REGISTRY
por: Sammour, Yasser, et al.
Publicado: (2022)

PRE-EXISTING CARDIOVASCULAR DISEASE, ACUTE KIDNEY INJURY, AND CARDIOVASCULAR OUTCOMES IN HOSPITALIZED BLACKS WITH COVID-19 INFECTION
por: Egbuche, Obiora, et al.
Publicado: (2021)

COVID-19-associated takotsubo cardiomyopathy
por: Gomez, Joanne Michelle Dumlao, et al.
Publicado: (2020)

Cardiac troponin T and I: back to basics
por: Mingels, Alma M, et al.
Publicado: (2023)

How is cardiac troponin released from cardiomyocytes?( )
por: Hammarsten, Ola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ovd64qro615r67unl57g0vf8t8